TESA1250

Vijaya Diagnostic Centre
3-6-16 & 17, Street No. 19, Himayatnagar, Hyderabad - 500 029
LABORATORY TEST REPORT
Regn Date : 5/23/2019 10:01 Sample Collection : 23/05/2019 10:04

Name : MR. NOOR SHAIK Print Date : 24/05/2019 08:31
Regn No : 231923484 Age / Sex : 35 Years / Male
Ref By : Dr. SREEKANTH APPASANI Regn Centre : Tolichowki - 23
Sample Type : Serum Ref no. :
VITAMIN-D (25-HYDROXY, D2+D3) - TOTAL

TEST NAME RESULT BIOLOGICAL REFERENCE INTERVAL
25 (OH) VIT D2 Ergocalciferol : 3.32 ng/mL Specific reference range for

Vitamin D2 is not available .
25 (OH) VIT D3 Cholecalciferol : 12.50 ng/mL Specific reference range for

Vitamin D3 is not available .
25 (OH) VIT D TOTAL (Vit D2 + Vit D3) : 15.82 ng/mL Deficiency : < 20
Insufficiency : 20 -30
Sufficiency : 30 - 100
Toxicity : >100
Method : Liquid Chromatography Tandem Mass Spectrometry.
Interpretation :
---------------
- Vitamin D is a steroid hormone involved in the intestinal absorption of calcium and regulation of calcium hemostasis.
- Vitamin D is essential for the formation and maintenance of strong, healthy bones.
- 25 OH Vitamin D is the major circulating form of Vitamin D and precursor of active form of 1, 25, di hydroxy Vitamin D.
- Vitamin D occurs in two forms, D2 ergocalciferol (plant origin) and D3 cholecalciferol (sunlight origin) in the body.
- Vitamin D deficiency can result from inadequate exposure to the sun, inadequate alimentary intake, decreased absorption,
abnormal metabolism or Vitamin D resistance. Recently many chronic disease such as cancer, high blood pressure, osteoporosis
and several autoimmune diseases have been linked to Vitamin D deficiency.
- 25(OH) Vit-D is a reliable indicator of the Vitamin D status because the serum or plasma levels of it reflect the storage
levels of Vitamin D in our body. Lower levels of 25(OH) Vit-D correlates with the clinical symptoms of Vitamin D deficiency.
- Vitamin D2 and Vitamin D3 added together is total Vitamin D.
DR.BIKASH K CHAUDHURY
HOD & CONSULTANT BIOCHEMIST
Released Date 23/05/2019 16:30 Page 1 of 1

*231923484*

TSH (THYROID STIMULATING HORMONE)

TSH : 1.88 Adult : 0.35-5.5 µIU/mL

Method : Chemiluminescence Immuno Assay (CLIA)
Comments / Interpretation :
---------------------------------
- Patient preparation is particularly important for hormone studies, results of which may be markedly affected by
many factors such as stress, position, fasting state, time of the day, preceding diet and drug therapy.
- TSH controls biosynthesis and release of thyroid hormones T3 & T4.
- TSH levels are increased in primary hypothyroidism, insufficient thyroid hormone replacement therapy, Hashimotos
thyroiditis, use of amphetamines, dopamine antagonists, iodine containing agents, lithium and iodine induced or deficiency
goiter.
- Increase in TSH is also seen in external neck irradiation, subtotal thyroidectomy, neonatal period, thyrotoxicosis due to
pituitary causes, euthyroid sick syndrome and presence of TSH antibodies.
- Decrease in TSH levels are seen in Toxic multinodular goiter, thyroid adenoma, Graves disease, thyroiditis, extrathyroidal
thyroid hormone source, over replacement of thyroid hormone in treatment of hypothyroidism, secondary hypothyroidism,
severe dehydration, first trimester of pregnancy.
DR ROHIT KUMAR B
Certificate # MC-2657 CONSULTANT BIOCHEMIST

*231923484* NABL Accredited

C-REACTIVE PROTEIN (CRP)

C - Reactive Protein : 2.2 Positive : >=5mg/L

Negative : <5mg/L
Method: Immono Turbidimetry
---------------------------------
- CRP exhibits dramatic increase in concentration following acute or chronic inflammation that may accompany bacterial
infections - the most potent stimulus to CRP production; autoimmune or immune complex disease, tissue necrosis,malignancy,
myocardial infarction, and trauma. The increase occurs within 24-48 hours and the level may be 2000 times
normal.
- In many cases the changes in plasma CRP level precede changes in the clinical symptoms.
- The degree of elevation of CRP reflects the mass or activity of the inflamed tissue and in acute inflammation or infection
correlates well with disease activity.
- Because the increase is non-specific, it cannot be interpreted without a complete clinical history, and even then, only by
comparison with previous values.
- A persistently raised CRP level generally indicates that therapy is ineffective.
- Normal CRP levels do not exclude the presence of minor degrees of acute, localized inflammation or some chronic diseases
such as SLE and ulcerative colitis.
CREATININE
Creatinine : 1.1 Adult Male : 0.7 - 1.2 mg/dL

Neonate : 0.3 - 1.0 mg/dL
Infant : 0.2 - 0.4 mg/dL
Children : 0.3 - 0.8 mg/dL
Method : Jaffe Kinetic IDMS
-------------------------------
- Useful in the diagnosis of renal insufficiency and is more specific and sensitive indicator of renal disease than of BUN.
- Use of simultaneous BUN and creatinine levels provide more information in the diagnosis of renal insufficiency.
DR ROHIT KUMAR B


Sample Type : Fluoride Plasma Ref no. :
RANDOM PLASMA GLUCOSE (RPG)

Plasma Glucose (Random) : 97 Normal : 70-140 mg/dL

Impaired Glucose Tolerance : 141-199 mg/dL
Diabetes : >/=200 mg/dL
Method : Hexokinase
---------------------------------
- ADA Guidelines (2018) are adopted for the evaluation of Diabetic Status.
DR ROHIT KUMAR B


Sample Type : Whole Blood - EDTA Ref no. :
COMPLETE BLOOD PICTURE (CBP)

Haemoglobin : 16.1 13.0 - 17.0 g/dL

Photometric measurement
Total RBC Count : 5.88 4.5 - 5.5 millions/cumm

Coulter Principle
Packed Cell Volume / Hematocrit : 50.2 40.0 - 50.0 Vol%

Calculated
MCV : 85.4 83.0 - 101.0 fl

Derived from RBC Histogram
MCH : 27.4 27 - 32 pg
Calculated
MCHC : 32.1 31.5 - 34.5 gm/dL

Calculated
RDW : 16 11.6 - 14.0 %

Derived from RBC Histogram
Total WBC Count : 6800 4000 - 10000 Cells/cumm

Coulter Principle
Differential count
Neutrophils : 44 40 - 80 %
VCSn Technology / Microscopy
Lymphocytes : 44 20 - 40 %
Eosinophils : 2 1-6 %
Monocytes : 9 2 - 10 %
Basophils : 1 0-2 %
Absolute Leucocyte Count
Absolute Neutrophil Count : 2992 2000 - 7000 Cells/cumm

Method : Calculation
Absolute Lymphocyte Count : 2992 1000 - 3000 Cells/cumm

Absolute Eosinophil Count : 136 20 - 500 Cells/cumm

Absolute Monocyte Count : 612 200 - 1000 Cells/cumm



COMPLETE BLOOD PICTURE (CBP)

Platelet Count : 215000 150000 - 410000 /cumm

Coulter Principle
Peripheral Smear
RBC : Normocytic Normochromic with anisocytosis

Microscopy : Leishman stain/Modified Giemsa Stain
WBC : Normal in morphology,maturity and distribution
Platelets : Adequate
Microscopy : Leishman stain/Modified Giemsa Stain
Method : Microscopy of Leishman stained smear
DR.ASIMA MUBEEN QUADRI

Certificate # MC-2657 CONSULTANT PATHOLOGIST


ERYTHROCYTE SEDIMENTATION RATE (ESR)

Erythrocyte Sedimentation Rate (ESR) : 5 0 - 15 mm/hr

Method : Automated (Modified Westergrens)
----------------------------------
- ESR is a nonspecific phenomenon, clinically useful in disorders associated with an increased production of acute phase proteins.
- Elevated in acute and chronic infections and malignancies.
- Extremely high ESR values are seen in multiple myeloma, leukemia, lymphoma, breast and lung carcinomas, rheumatoid
arthritis, SLE and pulmonary infarction.
DR.ASIMA MUBEEN QUADRI

Certificate # MC-2657 CONSULTANT PATHOLOGIST


LIPID PROFILE (LP)

Serum Status : Clear
Triglycerides : 389 Desirable Level : < 150 mg/dL

Borderline : 150 - 199 mg/dL
High : 200 - 499 mg/dL
Very High : > 499 mg/dL
Method : GPO-POD
Total Cholesterol : 373 Desirable Level : < 200 mg/dL

Borderline : 200 - 239 mg/dL
Undesirable : > 239 mg/dL
Method : CHOD-POD
LDL Cholesterol. : 234 Optimal : < 100 mg/dL

Near Optimal : 100 - 129 mg/dL
Borderline High : 130 - 159 mg/dL
High : 160 - 189 mg/dL
Very High : > 189 mg/dL
Method: Calculation
HDL Cholesterol : 61 Desirable Level : > 59 mg/dL

Optimal : 40 - 59 mg/dL
Undesirable : < 40 mg/dL
Method : Enzymatic Immunoinhibition
VLDL : 78 < 30 mg/dL

Method: Calculation
Total Cholesterol/HDL Cholesterol Ratio : 6.11 Low Risk : 3.3 - 4.4

Average Risk : 4.5 - 7.1
Moderate Risk : 7.2 - 11.0
Method: Calculation
LDL Cholesterol/HDL Cholesterol Ratio : 3.84 Desirable Level : 0.5 - 3.0

Borderline Risk : 3.0 - 6.0
High Risk : > 6.0
Method: Calculation
---------------------------------
- Lipid profile is a panel of blood tests that serves as an initial broad medical screening tool for abnormalities in lipids, the
results of this tests can identify certain genetic diseases and can determine approximate risks for cardiovascular disease,
certain forms of pancreatitis and other diseases.
DR ROHIT KUMAR B


LIVER FUNCTION TEST - A (LFT-A)

Total Bilirubin : 0.6 0.3 - 1.2 mg/dL

Method : Dichlorophenyl Diazonium Tetrafluroborate
Conjugated Bilirubin : 0.1 Less than 0.4 mg/dL

Unconjugated Bilirubin : 0.5 0.3 - 1.00 mg/dL

+ Calculation
ALT/SGPT : 149 Male (Adult) : 0 - 50 U/L

Newborn/Infant : 13 - 45 U/L
Method : IFCC without P-5-P
AST/SGOT : 86 Male (Adult) : 0 - 50 U/L

Newborn : 25 - 75 U/L
Infant : 15 - 60 U/L
Method : IFCC without P-5-P
Alkaline Phosphatase : 53 30 - 120 U/L

Method : Kinetic PNPP- AMP
Total Protein (TP) : 7.1 6.6 - 8.3 g/dL

Method : Biuret
Albumin : 4.5 Adult : 3.5 - 5.2 g/dL

New Born (0-4 days) : 2.8 - 4.4 g/dL
Method : Bromocresol Green (BCG)
Globulin : 2.6 1.8 - 3.6 g/dL

Method : Biuret + Bromocresol Green + Calculation
Albumin / Globulin (A/G) Ratio : 1.7 0.8 - 2.0
Gamma-Glutamyl Transferase (GGT) : 129 0 - 55 U/L

Method : UV Kinetic
---------------------------------
- Liver function test aid in the diagnosis of various pre hepatic, hepatic & post hepatic causes of dysfunction like hemolytic
anemias, viral & alcoholic hepatitis and cholestasis of obstructive causes.
- The test encompasses hepatic excretory, synthetic function and also hepatic parenchymal cell damage.
- LFT helps in evaluating severity, monitoring therapy and assessing prognosis of liver disease and dysfunction.
DR ROHIT KUMAR B


TESA1250

Uploaded by

Document Information

Original Description:

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

TESA1250

Uploaded by

Copyright:

Available Formats

Vijaya Diagnostic Centre

LABORATORY TEST REPORT

Regn Date : 5/23/2019 10:01 Sample Collection : 23/05/2019 10:04

VITAMIN-D (25-HYDROXY, D2+D3) - TOTAL

25 (OH) VIT D2 Ergocalciferol : 3.32 ng/mL Specific reference range for

25 (OH) VIT D3 Cholecalciferol : 12.50 ng/mL Specific reference range for

Released Date 23/05/2019 16:30 Page 1 of 1

LABORATORY TEST REPORT

TSH (THYROID STIMULATING HORMONE)

TSH : 1.88 Adult : 0.35-5.5 µIU/mL

Released Date 23/05/2019 18:44 Page 1 of 8

LABORATORY TEST REPORT

C-REACTIVE PROTEIN (CRP)

C - Reactive Protein : 2.2 Positive : >=5mg/L

Creatinine : 1.1 Adult Male : 0.7 - 1.2 mg/dL

Released Date 23/05/2019 15:15 Page 2 of 8

LABORATORY TEST REPORT

RANDOM PLASMA GLUCOSE (RPG)

Plasma Glucose (Random) : 97 Normal : 70-140 mg/dL

Released Date 23/05/2019 14:53 Page 3 of 8

LABORATORY TEST REPORT

COMPLETE BLOOD PICTURE (CBP)

Haemoglobin : 16.1 13.0 - 17.0 g/dL

Total RBC Count : 5.88 4.5 - 5.5 millions/cumm

Packed Cell Volume / Hematocrit : 50.2 40.0 - 50.0 Vol%

MCV : 85.4 83.0 - 101.0 fl

MCHC : 32.1 31.5 - 34.5 gm/dL

RDW : 16 11.6 - 14.0 %

Total WBC Count : 6800 4000 - 10000 Cells/cumm

Absolute Neutrophil Count : 2992 2000 - 7000 Cells/cumm

Absolute Lymphocyte Count : 2992 1000 - 3000 Cells/cumm

Absolute Eosinophil Count : 136 20 - 500 Cells/cumm

Absolute Monocyte Count : 612 200 - 1000 Cells/cumm

Released Date 23/05/2019 15:12 Page 4 of 8

LABORATORY TEST REPORT

COMPLETE BLOOD PICTURE (CBP)

Platelet Count : 215000 150000 - 410000 /cumm

RBC : Normocytic Normochromic with anisocytosis

WBC : Normal in morphology,maturity and distribution

Method : Microscopy of Leishman stained smear

DR.ASIMA MUBEEN QUADRI

Released Date 23/05/2019 15:12 Page 5 of 8

LABORATORY TEST REPORT

ERYTHROCYTE SEDIMENTATION RATE (ESR)

Erythrocyte Sedimentation Rate (ESR) : 5 0 - 15 mm/hr

DR.ASIMA MUBEEN QUADRI

Released Date 23/05/2019 15:14 Page 6 of 8

LABORATORY TEST REPORT

LIPID PROFILE (LP)

Serum Status : Clear

Triglycerides : 389 Desirable Level : < 150 mg/dL

Total Cholesterol : 373 Desirable Level : < 200 mg/dL

LDL Cholesterol. : 234 Optimal : < 100 mg/dL

HDL Cholesterol : 61 Desirable Level : > 59 mg/dL

VLDL : 78 < 30 mg/dL

Total Cholesterol/HDL Cholesterol Ratio : 6.11 Low Risk : 3.3 - 4.4

LDL Cholesterol/HDL Cholesterol Ratio : 3.84 Desirable Level : 0.5 - 3.0

Released Date 23/05/2019 15:15 Page 7 of 8

LABORATORY TEST REPORT

LIVER FUNCTION TEST - A (LFT-A)

Total Bilirubin : 0.6 0.3 - 1.2 mg/dL

Conjugated Bilirubin : 0.1 Less than 0.4 mg/dL

Unconjugated Bilirubin : 0.5 0.3 - 1.00 mg/dL